NPCE · NeuroPace Inc · Executive Compensation

$14.50 -0.26 (-1.76%) At close · Sep 9

Russell 2000 member Rebalance outlook locked

Market Cap

$497.70M

34.32M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joel Becker	President and Chief Executive Officer	$567,567	—	$587,340	$701,850	$551,810	—	$2,408,566
Patrick F. Williams	Chief Financial Officer	$263,461	—	$539,759	$650,452	$192,263	—	$1,645,935
Martha Morrell	Chief Medical Officer	$489,842	—	$140,634	$168,183	$235,473	—	$1,034,132
Rebecca Kuhn	Former Chief Financial Officer, Vice President, Finance and Administration	$268,166	—	$117,468	$140,441	—	$320,233	$846,308

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joel Becker	President and Chief Executive Officer	$528,667	—	$897,762	$1,206,751	$391,714	—	$3,024,894
Martha Morrell	Chief Medical Officer	$486,702	—	$213,875	$287,514	$181,460	—	$1,169,551
Rebecca Kuhn	Chief Financial Officer, Vice President, Finance and Administration	$416,205	—	$213,875	$287,514	$175,712	—	$1,093,306

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Favet	Former President and Chief Executive Officer	$288,470	—	$1,201,500	—	—	$689,204	$2,179,174
Joel Becker	President and Chief Executive Officer	$248,333	—	—	$1,023,341	$240,000	—	$1,511,674
Martha Morrell	Chief Medical Officer	$468,502	—	$380,000	—	$260,174	—	$1,108,676
Rebecca Kuhn	Chief Financial Officer, Vice President, Finance and Administration	$403,545	—	$380,000	—	$211,366	—	$994,911

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Favet	Former President and Chief Executive Officer	$538,667	—	$1,256,148	$1,249,945	$161,543	—	$3,206,303
Martha Morrell	Chief Medical Officer	$453,000	—	$381,094	$378,797	$102,538	—	$1,315,429

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Favet	President and Chief Executive Officer	$505,833	—	$611,820	$629,100	$329,588	—	$2,076,341
Irina Ridley	General Counsel and Corporate Secretary	$359,167	—	$130,748	$415,631	$102,938	—	$1,008,484
Martha Morrell	M.D., Chief Medical Officer	$435,679	—	$188,305	$193,124	$147,825	—	$964,933

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Favet	President and Chief Executive Officer	$411,923	$25,000	—	$13,363	$221,306	—	$671,592
Martha Morrell	M.D., Chief Medical Officer	$397,975	—	—	$3,802	$82,205	—	$483,982

Executive changes

Person	Role	Change	Effective	Filed
Patrick F. Williams	Chief Financial Officer	Appointed	2025-06-20	2025-06-24
Rebecca Kuhn	Chief Financial Officer and Vice President, Finance and Administration	Resigned	2025-06-20	2025-06-24
Scott Huennekens	director	Appointed	2025-01-06	2025-01-08

Key facts CIK 1528287 CUSIP 641288105 13F (30d) 81 filings 81 filers Visit website Investor relations